190 related articles for article (PubMed ID: 7944868)
1. [Management of patients with risk of sudden death. The amiodarone example].
Djian J
Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
[TBL] [Abstract][Full Text] [Related]
2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
3. [What is the latest in anti-arrhythmia therapy?].
Gloor HO
Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
[TBL] [Abstract][Full Text] [Related]
6. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
Zarembski DG; Nolan PE; Slack MK; Caruso AC
Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of amiodarone.
Nolan PE; Nappi J; Pollak PT
Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
Gambhir DS
Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
[No Abstract] [Full Text] [Related]
9. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Funck-Brentano C
Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
[TBL] [Abstract][Full Text] [Related]
11. [Amiodarone and secondary prevention. The EMIAT study].
Munoz A
Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998
[TBL] [Abstract][Full Text] [Related]
12. [Antiarrhythmic agents: current situation].
Bonhorst D
Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
[TBL] [Abstract][Full Text] [Related]
13. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?].
Galinier M; Bounhoure JP
Arch Mal Coeur Vaiss; 1999 Jun; 92(6):727-32. PubMed ID: 10410811
[TBL] [Abstract][Full Text] [Related]
15. [Antiarrhythmic agents in the prevention of sudden cardiac death].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
[TBL] [Abstract][Full Text] [Related]
17. [Anti-arrhythmic therapy and cardiac failure].
Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
[TBL] [Abstract][Full Text] [Related]
18. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone: a late comer.
Futterman LG; Lemberg L
Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
[TBL] [Abstract][Full Text] [Related]
20. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
Kuck KH
Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
